IMX .93 - Implant Sciences to Increase Asia-Pacific Presence
Distributor Support Office to Be Established in Beijing; Company Ships Additional Explosive Detection Systems into the Region
Jan 29, 2008 9:00:00 AM
Copyright Business Wire 2008
View Additional ProfilesWAKEFIELD, Mass.--(BUSINESS WIRE)--
Implant Sciences Corporation (AMEX: IMX) a leading manufacturer of advanced security products for the Security, Safety and Defense (SS&D) market, including explosives detection technology, today announced it plans to expand its Asia-Pacific presence. John Zhang, Ph.D., recently joined the Company as Director, Business Development, Asia-Pacific Region, reporting to Richard Meyerhoff, VP Worldwide Sales and Service. Dr. Zhang will strengthen the links between the Company and key distributors in the Chinese markets such as Beijing Ritchie and Beijing Fulong, two distributors who have built the largest installed base of the Company's products in the world. Additionally, he will lead distributor recruitment and support efforts for the growing installed base of the Company's handheld and benchtop explosives detection equipment throughout other parts of the Asia-Pacific region, including such nations as Japan, Taiwan, Korea, Thailand, Vietnam, Indonesia, and other locations.
Dr. Zhang, who is also fluent in Mandarin Chinese, received his Ph.D. in Nuclear Engineering from the Massachusetts Institute of Technology and a Masters degree in Electrical and Systems Engineering from the University of Connecticut. Having over 24 years of experience in research and development, systems engineering, software development, business development, and distribution channel management in the Asia-Pacific theatre represents a well rounded skill set for the wide range of sales growth initiatives planned for the region.
Richard Meyerhoff commented, "China has been our most productive sales territory and we expect this trend to continue. Through the efforts of our leading distributors there, we continue to receive multiple unit orders and anticipate fulfilling the majority of our current backlog to this region in the 3rd quarter. We also believe the upcoming 2008 Olympics, to be held in Beijing in August, could provide additional near term opportunities for sales of our security products. The establishment of a local support office in this region reaffirms our commitment to existing and new customers there, along with the opportunity to expand our capabilities in this important part of the world. We are fortunate to have retained Dr. Zhang to head our business development efforts in the Asia-Pacific territory. His background is well-suited to promote the sales of our security products and the development of new strategic partnerships. We continue to evaluate other international territories where the distributor network could benefit by this type of direct support from the Company."
About Implant Sciences
Implant Sciences develops, manufactures and sells products through its primary business units: (i) explosives trace detection (ETD) systems for homeland security, defense, and other security related applications and (ii) state of the art services for the medical and semiconductor industries. The Company has developed proprietary technology used in its commercial portable and bench-top ETD systems, which ship to a growing number of locations domestically and around the world.
The Company's ETD products address a growing range of needs in the Safety, Security, and Defense (SS&D) market including aviation, cargo, transportation, and other related elements of the government and commercial infrastructure. In addition to its SS&D market focus, the Company provides high technology coatings for a variety of medical products at its main facility in Wakefield, Massachusetts and provides ion implantation services to the semiconductor industry from its location in Sunnyvale, California. For further details on the Company and its products, please visit the Company's new website at www.implantsciences.com.
Implant Sciences believes this press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements.
For further information, you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission, including its Annual Report on Form 10K for the period ended June 30, 2007 and Quarterly Report for the period ended September 30, 2007. The Company assumes no obligation to update the information contained in this press release.
Source: Implant Sciences Corporation |
